Remove Access Remove Document Remove Events Remove Extraction
article thumbnail

The Valens Company Achieves Access to GMP Manufacturing in Australia & Expands International Footprint to Asia-Pacific through Exclusive Partnership with Epsilon Healthcare

Cannabis Law Report

Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).

Access 97
article thumbnail

 Columbia Care Launches the UK’s Broadest Portfolio of Doseable Medical Cannabis Extract Vaporizer Pens; First Company to Manufacture Extract Vaporization Products in the UK

Cannabis Law Report

NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Flora Growth Closes Investment in Hoshi, Provides Clear Expected Pathway To European Distribution

Cannabis Law Report

Hoshi will use commercially reasonable efforts to grant Flora access to its European Union Good Manufacturing Practices (“EU-GMP”) auditors for the purposes of assisting Flora to obtain EU-GMP certification at its Cosechemos cultivation and extraction facility in Colombia. This document contains forward-looking statements.

Events 105
article thumbnail

Flora Growth Launches Cutting-Edge Global Cannabis Distribution Strategy, Implements Pharmaceutical Standards For Its Supply Chain

Cannabis Law Report

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. This document contains forward-looking statements. Cautionary Statement Concerning Forward-Looking Statements.

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. Data extraction.

Safety 52
article thumbnail

Lowell Farms Commissioning First-of-its-Kind Cannabis Processing Facility in Salinas Valley

Cannabis Law Report

EST. Registration can be accessed at [link]. CSE:LOWL; OTCQX:LOWLF) is a California-based vertically-integrated cannabis company with advanced production capabilities supporting every step of the supply chain, including cultivation, extraction, manufacturing, brand sales, marketing, and distribution. ABOUT LOWELL FARMS INC.

article thumbnail

Chemistree Investee ImmunoFlex™ Completes Clinical Study and Submits US and International Patent Applications

Cannabis Law Report

In this latest study, traditional blood chemistry markers were not informative; however, genomic analysis of the immune system’s T cell receptor recognition regions (called CDR3’s) extracted from patient RNA showed immune system changes resulting from treatment. For more information, visit www.Chemistree.ca. Karl Kottmeier” President.